SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950144-01-002505
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
2
Group Members
PHARMABIO DEVELOPMENT INCQUINTILES TRANSNATIONAL CORP

Document Format Files

Seq Description Document Type Size
1 THE MEDICINES COMPANY/QUINTILES TRANSNATIONAL g66926bsc13g.txt SC 13G 14434
2 JOINT FILING AGREEMENT g66926bex99-1.txt EX-99.1 2410
  Complete submission text file 0000950144-01-002505.txt   19019
Mailing Address 4709 CREEKSTONE DR STE 300 DURHAM NC 27703-8411
Business Address 4709 CREEKSTONE DR RIVERBIRCH BLDG STE 200 DURHAM NC 27703-8411 9199982000
QUINTILES TRANSNATIONAL CORP (Filed by) CIK: 0000919623 (see all company filings)

IRS No.: 561714315 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address
Business Address ONE CAMBRIDGE CTR CAMBRIDGE MA 02142 6172259099
MEDICINES CO/ MA (Subject) CIK: 0001113481 (see all company filings)

IRS No.: 043324394 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60201 | Film No.: 1539552
SIC: 2834 Pharmaceutical Preparations